Recurrent presence of the PLCG1 S345F mutation in nodal peripheral T-cell lymphomas

Haematologica

Volumn 100, Issue 1, 2015, Pages e25-e27

  Manso, Rebeca ^a   Rodríguez Pinilla, Socorro M ^a   González Rincón, Julia ^b   Gómez, Sagrario ^b   Monsalvo, Silvia ^a   Llamas, Pilar ^a   Rojo, Federico ^a   Pérez Callejo, David ^b   Cereceda, Laura ^c   Limeres, Miguel A ^d   Maeso, Carmen ^e   Ferrando, Lucía ^f   Pérez Seoane, Carlos ^g   Rodríguez, Guillermo ^g   Arrinda, José M ^h   García Bragado, Federico ⁱ   Franco, Renato ^j   Rodriguez Peralto, José L ^k   González Carreró, Joaquin ^l   Martín Dávila, Francisco ^m   Piris, Miguel A ^c   Sánchez Beato, Margarita ^b   more..

^a UAM)   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^d Pathology Department Hospital U Canarias Dr Negrín Gran Canaria   (Spain)

^e Pathology Department   (Spain)

^f HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

^g HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^h Hospital del Bidasoa   (Spain)

ⁱ Instituto de Investigación Sanitaria de Navarra   (Spain)

^j NATIONAL CANCER INSTITUTE   (Italy)

^k HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^l Servicio Gallego de Salud   (Spain)

^m HOSPITAL GENERAL UNIVERSITARIO DE CIUDAD REAL   (Spain)

more..

Author keywords

Peripheral T cell lymphomas; PLCG1

Indexed keywords

CD3 ANTIGEN; CD30 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; KI 67 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; PREDNISONE; PROTEIN P50; PROTEIN P52; T LYMPHOCYTE RECEPTOR; VINCRISTINE; ANTINEOPLASTIC AGENT; PHOSPHOLIPASE C GAMMA; PLCG1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; CANCER RECURRENCE; DNA MICROARRAY; FEMALE; GENE; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PHOSPHOLIPASE C GAMMA 1 GENE; T CELL LYMPHOMA; TREATMENT RESPONSE; CANCER STAGING; ENZYME IMMUNOASSAY; FOLLOW UP; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; MUTATION; PATHOLOGY; PERIPHERAL T CELL LYMPHOMA; PROGNOSIS; SURVIVAL RATE; TISSUE MICROARRAY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOMARKERS, TUMOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; MUTATION; NEOPLASM STAGING; PHOSPHOLIPASE C GAMMA; PROGNOSIS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS;

EID: 84920200929     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2014.113696     Document Type: Letter

References (15)

1. Escalon MP, Liu NS, Yang Y, Hess M, Walker PL, Smith TL, et al. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience. Cancer. 2005;103(10):2091-8.
2. Serwold T, Hochedlinger K, Swindle J, Hedgpeth J, Jaenisch R, Weissman IL. T-cell receptor-driven lymphomagenesis in mice derived from a reprogrammed T cell. Proc Natl Acad Sci USA. 2010; 107(44):18939-43.
3. Dierks C, Adrian F, Fisch P, Ma H, Maurer H, Herchenbach D, et al. The ITK-SYK fusion oncogene induces a T-cell lymphoproliferative disease in mice mimicking human disease. Cancer Res. 2010; 70(15):6193-204.
4. Feldman AL, Law M, Grogg KL, Thorland EC, Fink S, Kurtin PJ, et al. Incidence of TCR and TCL1 gene translocations and isochromosome 7q in peripheral T-cell lymphomas using fluorescence in situ hybridization. Am J Clin Pathol. 2008;130(2):178-85.
5. Palomero T, Couronne L, Khiabanian H, Kim MY, Ambesi- Impiombato A, Perez-Garcia A, et al. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat Genet. 2014;46(2):166-70.
6. Manso R, Sanchez-Beato M, Monsalvo S, Gomez S, Cereceda L, Llamas P, et al. The RHOA G17V gene mutation occurs frequently in peripheral T-cell lymphoma and is associated with a characteristic molecular signature. Blood. 2014;123(18):2893-4.
7. Sakata-Yanagimoto M, Enami T, Yoshida K, Shiraishi Y, Ishii R, Miyake Y, et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet. 2014;46(2):171-5.
8. de Leval L, Rickman DS, Thielen C, Reynies A, Huang YL, Delsol G, et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood. 2007;109(11):4952-63.
9. Rodriguez-Pinilla SM, Sanchez ME, Rodriguez J, Garcia JF, Sanchez-Espiridion B, Lamana LF, et al. Loss of TCR-beta F1 and/or EZRIN expression is associated with unfavorable prognosis in nodal peripheral T-cell lymphomas. Blood Cancer J. 2013;3:e111.
10. Qi Q, August A. Keeping the (kinase) party going: SLP-76 and ITK dance to the beat. Sci STKE. 2007;2007(396):pe39.
11. Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol. 1997;15:707-47.
12. Roose JP, Mollenauer M, Gupta VA, Stone J, Weiss A. A diacylglycerol- protein kinase C-RasGRP1 pathway directs Ras activation upon antigen receptor stimulation of T cells. Mol Cell Biol. 2005; 25(11):4426-41.
13. Sun Z, Arendt CW, Ellmeier W, Schaeffer EM, Sunshine MJ, Gandhi L, et al. PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature. 2000;404(6776):402-7.
14. Vaque JP, Gomez-Lopez G, Monsalvez V, Varela I, Martinez N, Perez C, et al. PLCG1 mutations in cutaneous T-cell lymphomas. Blood. 2014;123(13):2034-43.
15. Yoo HY, Sung MK, Lee SH, Kim S, Lee H, Park S, et al. A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma. Nat Genet. 2014;46(4):371-5.